Affordable Access

Access to the full text

Evaluation of uro-oncological surgical treatment during the Sars-CoV-2 pandemic in a Brazilian tertiary oncology institution, the new world epicenter

Authors
  • Silva, Gabriel Carvalho dos Anjos1, 2
  • Abe, Daniel Kanda1, 2
  • Pedrenho, Rubens Neto1, 2
  • Vilares, Rafael Nascimento1, 2
  • Cordeiro, Mauricio Dener1, 2
  • Coelho, Rafael Ferreira1, 2
  • Nahas, William Carlos1, 2
  • 1 Instituto do Câncer de São Paulo - ICESP, São Paulo, SP, Brasil., São Paulo SP , (Brazil)
  • 2 Divisão de Urologia, Faculdade de Medicina, Universidade de São Paulo, SP, Brasil., São Paulo SP , (Brazil)
Type
Published Article
Journal
International Brazilian Journal of Urology : official journal of the Brazilian Society of Urology
Publisher
Sociedade Brasileira de Urologia
Publication Date
Feb 03, 2021
Volume
47
Issue
2
Pages
378–385
Identifiers
DOI: 10.1590/S1677-5538.IBJU.2020.0479
PMID: 33146983
PMCID: PMC7857743
Source
PubMed Central
Keywords
Disciplines
  • Original Article
License
Green

Abstract

Introduction: The rapid spread of coronavirus disease 2019 (COVID-19) has dramatic effects on individuals and health care systems. In our institute, a tertiary oncologic public hospital with high surgical volume, we prioritize maintaining cancer treatment as well as possible. The aim of this study is to evaluate if uro-oncological surgeries at pandemic are safe. Materials and Methods: We evaluated patients who underwent uro-oncological procedures. Epidemiological data, information on COVID-19 infection related to surgery and clinical characteristics of non-survival operative patients with COVID-19 infections were analyzed. Results: From 213 patients analyzed, Covid-19 symptoms were noticed in 8 patients at preoperative process or at hospital admission postponing operation; 161 patients were submitted to elective surgery and 44 to emergency surgery. From patients submitted to elective surgeries, we had 1 patient with laboratory confirmation of COVID-19 (0,6%), with mild symptoms and quick discharge. From the urgencies group, we had 6(13%) patients tested positive; 5 were taken to ICU with 4 deaths. Conclusion: Elective uro-oncological procedures at the COVID-19 epidemic period in a COVID-19-free Institute are safe, and patients who need urgent procedures, with a long period of hospitalization, need special care to avoid COVID-19 infection and its outcomes.

Report this publication

Statistics

Seen <100 times